Загрузка...
Tau Immunotherapy and Imaging
Disappointing findings from recent Phase III trials on amyloid-β (Aβ) immunotherapy for Alzheimer’s disease (AD) have shifted the focus of such treatments to the tau protein. As tau pathology correlates better with the degree of dementia than Aβ plaque burden, it is a more attractive target once cog...
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3946316/ https://ncbi.nlm.nih.gov/pubmed/24029727 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000354491 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|